Establish Targeted Radiopharmaceuticals as the Next Pillar of Oncology Drugs Through Innovating Novel Design Approaches, Showcasing Emerging Clinical Data, & Streamlining Isotope Supply & Distribution.
This is the meeting for anyone passionate about bringing the next wave of TRPs to patients. Whether you’re working in discovery, clinical development, manufacturing, or regulation, you’ll find practical insights, open conversations, and solutions you can act on.
For more information and to register, click here.
10-12 November, 2025 | Amsterdam, Netherlands
PACE (Pathways to Antimicrobial Clinical Efficacy) and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.
New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs.
